| Patent | Date |
|---|
Combination Of Pi3k Inhibitor And C-met Inhibitor
App 20220280523 - CAPONIGRO; Giordano ; et al. | 2022-09-08 |
Combinations of MDM2 inhibitors with inhibitors of ERK for treating cancers
Grant 11,406,627 - Caponigro , et al. August 9, 2 | 2022-08-09 |
Pharmaceutical combinations
Grant 11,376,239 - Caponigro , et al. July 5, 2 | 2022-07-05 |
Therapeutic Combinations Comprising A C-raf Inhibitor
App 20220008426 - CAPONIGRO; Giordano ; et al. | 2022-01-13 |
Mdm2 Inhibitors And Combinations Thereof
App 20210260059 - CAPONIGRO; Giordano ; et al. | 2021-08-26 |
Combination Of Ribociclib And Dabrafenib For Treating Or Preventing Cancer
App 20210186973 - CAPONIGRO; Giordano ; et al. | 2021-06-24 |
Therapeutic uses of a C-RAF inhibitor
Grant 10,973,829 - Caponigro , et al. April 13, 2 | 2021-04-13 |
Combinations Of Mdm2 Inhibitors With Inhibitors Of Erk For Treating Cancers
App 20200281910 - Caponigro; Giordano ; et al. | 2020-09-10 |
Combination Of Pi3k Inhibitor And C-met Inhibitor
App 20200253980 - Kind Code | 2020-08-13 |
Combination Therapy
App 20200246338 - Kind Code | 2020-08-06 |
Pharmaceutical Combinations
App 20200230108 - Caponigro; Giordano ; et al. | 2020-07-23 |
Combination therapy
Grant 10,548,894 - Caponigro , et al. Fe | 2020-02-04 |
Combinations Of The Cdk4/6 Inhibitor Lee011 And The Mek1/2 Inhibitor Trametinib, Optionally Further Comprising The Pi3k Inhibito
App 20190365741 - Caponigro; Giordano ; et al. | 2019-12-05 |
Therapeutic Uses Of A C-raf Inhibitor
App 20190358236 - CAPONIGRO; Giordano ; et al. | 2019-11-28 |
Pharmaceutical combinations
Grant 10,485,788 - Caponigro , et al. Nov | 2019-11-26 |
Combination of PI3K inhibitor and c-MET inhibitor
App 20190350935 - Caponigro; Giordano ; et al. | 2019-11-21 |
Pharmaceutical combination comprising the PI3K inhibitor alpelisib and the B-RAF inhibitor dabrafenib; the use of such combination in the treatment or prevention of cancer
Grant 10,328,065 - Caponigro , et al. | 2019-06-25 |
Pharmaceutical combination comprising the PI3K inhibitor alpelisib and the CDK4/6 inhibitor ribociclib, and the use thereof in the treatment/prevention of cancer
Grant 10,328,066 - Caponigro , et al. | 2019-06-25 |
Therapeutic Uses Of A C-raf Inhibitor
App 20190175609 - CAPONIGRO; Giordano ; et al. | 2019-06-13 |
Pharmaceutical Combinations
App 20190105303 - Caponigro; Giordano ; et al. | 2019-04-11 |
Combination of PI3K Inhibitor and C-Met Inhibitor
App 20190083500 - Caponigro; Giordano ; et al. | 2019-03-21 |
Mdm2 Inhibitors And Combinations Thereof
App 20190060309 - Halilovic; Ensar ; et al. | 2019-02-28 |
Combination Therapy Using Pi3k Inhibitor And Mdm2 Inhibitor
App 20180318275 - CAPONIGRO; Giordano ; et al. | 2018-11-08 |
Pharmaceutical Combination Comprising (a) The Alpha-isoform Specific Pi3k Inhibitor Alpelisib (byl719) And (b) An Akt Inhibitor, Preferably Mk-2206, Afuresertib Or Uprosertib, And The Use Thereof In The Treatment/prevention Of Cancer
App 20180256557 - Caponigro; Giordano ; et al. | 2018-09-13 |
Combination Of Ribociclib And Dabrafenib For Treating Or Preventing Cancer
App 20180250302 - CAPONIGRO; Giordano ; et al. | 2018-09-06 |
Pharmaceutical Combinations Comprising (a) The Cyclin Dependent Kinase 4/6 (cdk4/6) Inhibitor Lee011 (=ribociclib), And (b) The Epidermal Growth Factor Receptor (egfr) Inhibitor Erlotinib, For The Treatment Or Prevention Of Cancer
App 20180243304 - Caponigro; Giordano ; et al. | 2018-08-30 |
A Pharmaceutical Combination Comprising The Pi3k Inhibitor Alpelisib And The Cdk4/6 Inhibitor Ribociclib, And The Use Thereof In The Treatment/prevention Of Cancer
App 20180243280 - Caponigro; Giordano ; et al. | 2018-08-30 |
Pharmaceutical Combination Comprising The Pi3k Inhibitor Alpelisib And The B-raf Inhibitor Dabrafenib; The Use Of Such Combination In The Treatment Or Prevention Of Cancer
App 20180243279 - Caponigro; Giordano ; et al. | 2018-08-30 |
Combination Therapy
App 20180221370 - Caponigro; Giordano ; et al. | 2018-08-09 |
Androgen receptor mutation
Grant 10,011,874 - Caponigro , et al. July 3, 2 | 2018-07-03 |
Combination therapy
Grant 9,913,844 - Caponigro , et al. March 13, 2 | 2018-03-13 |
Biomarkers Associated With Cdk Inhibitors
App 20180066322 - Caponigro; Giordano ; et al. | 2018-03-08 |
Pharmaceutical combination comprising binimetinib
Grant 9,867,825 - Caponigro , et al. January 16, 2 | 2018-01-16 |
Pharmaceutical combinations of a CDK4/6 inhibitor and a B-RAF inhibitor
Grant 9,700,557 - Caponigro , et al. July 11, 2 | 2017-07-11 |
Pharmaceutical combinations comprising a B-RAF inhibitor, and EGFR inhibitor and optionally a PI3K-.alpha. inhibitor
Grant 9,474,754 - Caponigro , et al. October 25, 2 | 2016-10-25 |
Combination Therapy
App 20160296520 - Caponigro; Giordano ; et al. | 2016-10-13 |
Novel Androgen Receptor Mutation
App 20160002727 - CAPONIGRO; Giordano ; et al. | 2016-01-07 |
Biomarkers Associated With Cdk Inhibitors
App 20150322528 - Caponigro; Giordano ; et al. | 2015-11-12 |
Pharmaceutical Combination Comprising Binimetinib
App 20150313902 - CAPONIGRO; Giordano ; et al. | 2015-11-05 |
Pharmaceutical Combinations Comprising a B-RAF Inhibitor, and EGFR Inhibitor and Optionally a PI3K-Alpha Inhibitor
App 20150265616 - Caponigro; Giordano ; et al. | 2015-09-24 |
Combination of PI3K Inhibitor and C-Met Inhibitor
App 20150216870 - Caponigro; Giordano ; et al. | 2015-08-06 |
Pharmaceutical Combinations of a CDK4/6 Inhibitor and a B-RAF Inhibitor
App 20150164897 - Caponigro; Giordano ; et al. | 2015-06-18 |
Method For Treating Haematological Cancers
App 20120258940 - Caponigro; Giordano ; et al. | 2012-10-11 |
| 